Bijal Shah, MD, Moffitt Cancer Center, Tampa, FL, shares some insights into the sequencing of immunotherapies in adults with acute lymphoblastic leukemia (ALL), highlighting the possibility of assigning agents such as inotuzumab ozogamicin or blinatumomab following CAR-T therapy. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.